ICM
SLGN icon

Invenomic Capital Management’s Silgan Holdings SLGN Stock Holding History

Invenomic Capital Management’s Portfolio SLGN Stock Details SLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11M Buy
+131,660
New +$5.26M 0.36% 78
2021
Q2 		– Sell
-10,410
Closed -$437K – 143
2021
Q1 		$437K Buy
+10,410
New +$406K 0.1% 102

Other funds holding SLGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Invenomic Capital Management's SLGN Position: Q2 2026 in Review

Invenomic Capital Management opened a new position in Silgan Holdings (SLGN) in Q2 2026: 131,660 shares worth $6.11M. The stake represents 0.36% of the portfolio and ranks #78 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in SLGN as recently as Q1 2021.

Invenomic Capital Management first reported a position in SLGN in Q1 2021 and has held it in 2 quarters since. 346 funds tracked by Wall St. Rank hold SLGN as of Q2 2026.

  • Invenomic Capital Management held 131,660 shares of Silgan Holdings worth $6.11M as of Q2 2026.
  • Silgan Holdings was a new Invenomic Capital Management position in Q2 2026.
  • Silgan Holdings made up 0.36% of Invenomic Capital Management's portfolio in Q2 2026, its #78 holding.
  • Invenomic Capital Management first reported a position in Silgan Holdings in Q1 2021 and has held it in 2 quarters since.
  • 346 funds tracked by Wall St. Rank held Silgan Holdings as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.